Breakthrough in treating one of the deadliest cancers

A new type of immunotherapy can significantly slow the progression of one of the most deadly cancers by three-quarters, a study found.

Experts found the CAR-T therapy 'remarkably effective' for treating patients with multiple myeloma, a type of blood that develops from cells in the bone marrow.

Trials found the drug, which goes by the brand name Carvykti, slowed disease progression by 74 per cent in patients who had become resistant to other medication.

Load More